Drug – bio-affecting and body treating compositions – Preparations characterized by special physical form – Implant or insert
Patent
1996-05-15
1997-09-02
Venkat, Jyothsan
Drug, bio-affecting and body treating compositions
Preparations characterized by special physical form
Implant or insert
424434, 424440, A61K 920
Patent
active
056629206
ABSTRACT:
A method for smoking cessation therapy is described that utilizing an improved nicotine lozenge to satisfy transient craving. The lozenge contains nicotine, a nonnutritive sweetener and an absorbent excipient.
REFERENCES:
patent: Re34089 (1992-10-01), Kydonieus et al.
patent: 4753800 (1988-06-01), Mozda et al.
patent: 4806356 (1989-02-01), Shaw
patent: 4837027 (1989-06-01), Lee et al.
patent: 4907605 (1990-03-01), Ray et al.
patent: 4908213 (1990-03-01), Govil et al.
patent: 4946853 (1990-08-01), Bannon et al.
patent: 4953572 (1990-09-01), Rose et al.
patent: 5004601 (1991-04-01), Snipes
patent: 5016652 (1991-05-01), Rose et al.
patent: 5055478 (1991-10-01), Cooper et al.
patent: 5069904 (1991-12-01), Masterson
patent: 5135752 (1992-08-01), Snipes
patent: 5135753 (1992-08-01), Baker et al.
patent: 5139790 (1992-08-01), Snipes
patent: 5156845 (1992-10-01), Grodberg
patent: 5174989 (1992-12-01), Tanaka et al.
patent: 5362496 (1994-11-01), Baker et al.
Encyclopedia of Chemical Technology, Third Edition, vol. 9, p.198 (1980).
Encyclopedia of Chemical Technology, Third Edition, vol. 15, p. 568 (1981).
The Merck Index, An Encyclopedia of Chemicals, Drugs, and Biologicals, Tenth Edition, p.5183 (1983).
EMDEX.RTM. (Dextrates, NF Hydrated), Revised November, 1995, pp. 1-4.
Pharmetrix-"Nicotine Smoking Cessation Therapeutic Systems," Technology Overview, May 12, 1993, Copy No.32, Pharmetrix Corp.
Lee, Emmet W. et al. "Cigarette Smoking, Nicotine Addiction, & Its Pharmacologic Treatment," Arch Inter Med/vol. 153, Jan. 11, 1993.
Sachs, David P.L. et al. "Effectiveness of a 16-Hour Transdermal Nicotine Patch in a Medical Practice Setting, Without Intensive Group Counseling," In Press: Arch Int Med.
Smith, Eric W. et al. "The Local Side Effects of Transdermally Absorbed Nicotine," Skin Pharmacol 1992:5:69-76.
McKenna, James P. et al. "Transdermal Nicotine Replacement and Smoking Cessation," American Family Physician Jun. 1992 pp.2595-2601.
Fiore, Michael C. et al. "Tobacco Dependence and the Nicotine Patch," JAMA, Nov. 18, 1992 vol. 268, No. 19 pp.2687-2694.
"Correspondence," The New England Journal of Medicine, Jan. 30, 1992, vol. 326 No. 5, pp. 344-345.
Product Insert for PROSTEP.TM. (nicotine transdermal system), Lederle Laboratories, 1992.
Soderling, Eva, et al. "Perspectives on xylitol-induced oral effects," Proc Finn Dent Soc 1991 87 No. 2.
Product Insert for Habitrol.TM. nicotine, Transdermal Therapeutic System, Basel Pharmaceuticals, 1991.
Sachs, David P.L. "Advances in Smoking Cessation Treatment*," Reprinted from Current Pulmonology, Chap.6,vol.12,'91, pp.140-197.
Tonnesen, Philip et al. "A Double-Blind Trial of a 16-Hour Transdermal Nicotine Patch in Smoking Cessation," The New England Journal of Medicine vol. 325, No. 5, 1991, pp.311-315.
Sachs, David P.L. et al. "Pharmacologic Approaches to Smoking Cessation," Clinics in Chest Medicine-vol. 12,No. 4,Dec. 1991 pp.769-791.
Bradlet, J. R. et al. "Buccal Absorption of Nicotine from Smokeless Tobacco Sachets," The Lancet, Dec. 14, 1985 p. 1370.
Gourlay, Steven G. et al. "Antismoking products," The Medical Journal of Australia vol. 153 Dec. 3/17, 1990 pp.699-707.
U.S. Department of Health and Human Services. "The Health Benefits of Smoking Cessation," U.S. Dept. of Heath & Human Services Public Health Service, Centers for disease Control, Center for Chronic Disease Prevention & Health Promotion, Office on Smolind & Health. DHHS Publication No. (DCD) 90-8416, 1990.
Muller, Ph. et al. "The Use of Transdermal Nicotine in Smoking Cessation," Lung Springer-Verlag, New York Inc. 1990, pp.445-453.
Olinger, Philip M. "Sweetening Sugar-Free Medications: Xylitol," Presented at Interphex.cndot.-USA Conference/Exhibition, May 8-11, 1990, New York.
Steuer, Jill D. et al. "Cigarette Craving and Subsequent Coping Responses Among Smoking Cessation Clinic Participants," Steuer-vol. 16, No. 2, 1989, pp.193-198.
Sachs, Davd P.L. "Nicotine Polacrilex: Practical Use Requirements*," Curr Pulmonol, Chapter 7, 10:141-158, 1989.
Excerpt from Oral Drug Delivery "Oral Mucosal Drug Delivery," 1989, Chapter 3, pp.183-190.
Graffner, Christina "Clinical experience with novel buccal and sublingual adminstration," Novel Drug Delivery and Its Therapeutic Application, Chapter 16, 1989, pp.159-165.
Sachs, David P.L. "Transdermal Nicotine for Smoking Cessation-Six-Month Results From Two Multicenter Controlled Clinical Trials," JAMA, Dec. 11, 1991-vol. 266, No. 22, pp.3133-3138.
Sachs, David P.L.et al. "Are Smokers Trying to Stop and Smokers Not Trying to Stop the Same Experimental Model?" Research Monograph Series, Problems of Drug Dependence 1989, Proceedings of the 51st Annual Scientific Meeting, The Committee on Problems of Drug Dependence, Inc., U.S. Dept. of Health and Human Services, pp.366-367 & Slide Sheets pp.1-7.
Pilot Study for "The Optimum Dose and Schedule for Nicotine Polacrilex Use," National Institute on Drug Abuse U.S. Public Health Service, 1988-1993, pp. 775.1-775.9.
Russell, Michael A.H. "Nicotine Replacement: The Role of Blood Nicotine Levels, Their Rate of Change, and Nicotine Tolerance," Nicotine Replacement: A Critical Evaluation, 1988, pp.63-94.
Makinen, Kauko K. "Sweeteners and prevention of dental caries," Preventive, Sep. 1988, vol. 78/No. 9, pp.57-66.
Sachs, David P.L. "Pharmacologic, Neuroendorcine, and Biobehavioral Basis for Tobacco Dependence*," Curr Pulmonol 8:371-406, 1987.
Warburton, David M. et al. "Facilitation of learning and state dependency with nicotine," Psychopharmacology (1986) 89:55-59.
Machacek, Dwaine A. et al. "Quantification of Cotinine in Plasma and Saliva by Liquid Chromatography," Clinical Chemistry vol. 32, No. 6, 1986 pp.979-982.
Sachs, David P.L."Cigarette Smoking-Health Effects & Cessation Strategies," Clinics in Geriatric Med.vol.2, No.2, May 1986 pp. 337-362.
Sachs, David P.L. "Nicotine Polacrilex: Clinical Promises Delivered & Yet to Come," The Pharmacologic Treatment of Tobacco Dependence: Proceedings of the World Congress, Nov. 4-5 1985, pp. 120-140.
Russell M.A.H. et al. & Bradley, J. R. et al. "Buccal Absorption of Nicotine from Smokeless to Tobacco Sachets," & Aortic Valve Replacement in Chronic Renal Failure, The Lancet Dec. 14, 1985, p.1370.
West, R. J. et al. "Effect of Nicotine Replacement on the Cigarette Withdrawal Syndrome," British Journal of Addiction 79 (1984) pp.215-219.
Hughes, John R. et al. "Effect of nicotine on the tobacco withdrawl syndrome*," Psychopharmacology (1984) 83:82-87.
Wesnes, Keith et al. "Effects of scopolamine and nicotine on human rapid information processing performance," Psychopharmacology (1984) 82:147-150.
Benowitz, Neal L. et al. "Smokers Of Low-Yield Cigarettes Do Not Consume Less Nicotine," Reprinted from The New England Journal of Medicine 309:139-142 (Jul. 21), 1983.
Szeztli, I. "Cyclodextrins and their inclusion complexes," Akademiai Kiado: Budapest, 1992, p.109.
Harrington, Neil "The craving factor in the treatment of smoking," Br. J. Soc. Clin. Psychol. (1978), 17, pp.363-371.
Jarvik, M.E. et al. "Inhibition of cigarette smoking by orally administered nicotine," Clinical Pharmacology & Therapeutics vol. 11, No. 4, 1970, pp.574-576.
Pharmacia AB
Venkat Jyothsan
LandOfFree
Nicotine lozenge and therapeutic method for smoking cessation does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Nicotine lozenge and therapeutic method for smoking cessation, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Nicotine lozenge and therapeutic method for smoking cessation will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-306257